Integer (NYSE:ITGR) VP Tommy Thomas Sells 884 Shares

Integer Holdings Corporation (NYSE:ITGR) VP Tommy Thomas sold 884 shares of Integer stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $70.15, for a total value of $62,012.60. Following the completion of the transaction, the vice president directly owned 3,596 shares in the company, valued at approximately $252,259.40. This represents a 19.73% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Integer Stock Up 1.8%

Shares of NYSE ITGR traded up $1.22 during midday trading on Friday, hitting $69.27. 229,779 shares of the stock traded hands, compared to its average volume of 605,196. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.45 and a current ratio of 3.71. The business has a 50 day moving average price of $92.45 and a two-hundred day moving average price of $107.61. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $146.36. The company has a market cap of $2.43 billion, a PE ratio of 28.90, a P/E/G ratio of 0.60 and a beta of 0.95.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, October 23rd. The medical equipment provider reported $1.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.68 by $0.11. Integer had a return on equity of 12.84% and a net margin of 4.75%.The firm’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.43 EPS. Integer has set its FY 2025 guidance at 6.290-6.430 EPS. On average, equities analysts predict that Integer Holdings Corporation will post 6.01 EPS for the current year.

Integer announced that its board has authorized a stock repurchase program on Tuesday, November 4th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the medical equipment provider to reacquire up to 8.3% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s leadership believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ITGR. Raymond James Financial reaffirmed an “outperform” rating and set a $95.00 price target (down previously from $143.00) on shares of Integer in a research report on Friday, October 24th. Wall Street Zen lowered Integer from a “buy” rating to a “hold” rating in a research note on Saturday, October 25th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Integer in a report on Friday, October 31st. Piper Sandler decreased their price target on shares of Integer from $155.00 to $82.00 and set an “overweight” rating for the company in a report on Friday, October 24th. Finally, Benchmark reissued a “hold” rating on shares of Integer in a report on Friday, October 24th. Four investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $96.75.

Institutional Investors Weigh In On Integer

A number of institutional investors have recently modified their holdings of the business. CWM LLC raised its holdings in Integer by 46.1% in the second quarter. CWM LLC now owns 355 shares of the medical equipment provider’s stock worth $44,000 after purchasing an additional 112 shares in the last quarter. Xponance Inc. increased its stake in Integer by 5.1% during the 1st quarter. Xponance Inc. now owns 2,518 shares of the medical equipment provider’s stock worth $297,000 after buying an additional 122 shares in the last quarter. GAMMA Investing LLC grew its stake in Integer by 20.2% during the 2nd quarter. GAMMA Investing LLC now owns 796 shares of the medical equipment provider’s stock valued at $98,000 after acquiring an additional 134 shares in the last quarter. Orion Porfolio Solutions LLC grew its stake in shares of Integer by 1.4% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 9,755 shares of the medical equipment provider’s stock valued at $1,200,000 after buying an additional 138 shares during the period. Finally, Ameritas Investment Partners Inc. raised its stake in shares of Integer by 4.4% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 3,521 shares of the medical equipment provider’s stock valued at $433,000 after acquiring an additional 148 shares during the period. Institutional investors own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.